Iodine‐123 Metaiodobenzylguanidine Scintigraphy and Iodine‐123 Ioflupane Single Photon Emission Computed Tomography in Lewy Body Diseases: Complementary or Alternative Techniques?

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Neuroimaging

• Publication date

  2014-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1552-6569.2012.00774.xPMID 23163913
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic accuracy of ¹²³I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: a meta-analysis of published studies.

  2012cited by this paper
• Diagnostic Performance of Myocardial Innervation Imaging Using MIBG Scintigraphy in Differential Diagnosis between Dementia with Lewy Bodies and Other Dementias: A Systematic Review and a Meta‐Analysis

  2012cited by this paper
• Sympathetic noradrenergic before striatal dopaminergic denervation: relevance to Braak staging of synucleinopathy

  2012cited by this paper
• MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis

  2012cited by this paper
• Pathological roles of α-synuclein in neurological disorders.

  2011cited by this paper
• Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: a systematic review and a meta-analysis.

  2011cited by this paper
• Dopaminergic imaging: clinical utility now and in the future

  2011cited by this paper
• Reply to Treglia et al.: 123I‐metaiodobenzylguanidine cardiac scintigraphy appears feasible despite proposed obstacles

  2011cited by this paper
• Advances in imaging in Parkinson's disease.

  2011cited by this paper
• Diagnostic Accuracy of Combined FP-CIT, IBZM, and MIBG Scintigraphy in the Differential Diagnosis of Degenerative Parkinsonism: A Multidimensional Statistical Approach

  2011cited by this paper
• Recent developments in innervation imaging using iodine-123-metaiodobenzylguanidine scintigraphy in Lewy body diseases

  2010cited by this paper
• Gammagrafía miocárdica con 123I-MIBG en el diagnóstico de la demencia con cuerpos de Lewy

  2010cited by this paper
• Cardiac sympathetic impairment parallels nigrostriatal degeneration in Probable Dementia with Lewy Bodies.

  2010cited by this paper
• [(123)I-MIBG myocardial scintigraphy in the diagnosis of Lewy body dementia].

  2010cited by this paper
• EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2

  2010cited by this paper
• Imaging dopamine transporters in Parkinson's disease.

  2010cited by this paper
• Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology

  2010cited by this paper
• Single-Photon Emission Computed Tomography in Diagnosis and Differential Diagnosis of Parkinson’s Disease

  2010cited by this paper
• Validation of cardiac 123I-MIBG scintigraphy in patients with Parkinson’s disease who were diagnosed with dopamine PET

  2009cited by this paper
• Imaging Improves Diagnosis of Dementia with Lewy Bodies

  2009cited by this paper
• Cardiac sympathetic neuroimaging: summary of the First International Symposium

  2009cited by this paper
• Combined use of DAT‐SPECT and cardiac MIBG scintigraphy in mixed tremors

  2009cited by this paper
• The role of DAT-SPECT in movement disorders

  2008cited by this paper
• Cerebral and Extracranial Neurodegeneration are Strongly Coupled in Parkinson’s Disease

  2007cited by this paper
• PET measurement of cardiac and nigrostriatal denervation in Parkinsonian syndromes.

  2006cited by this paper
• Diagnosis and management of dementia with Lewy bodies

  2005cited by this paper
• FP‐CIT and MIBG scintigraphy in early Parkinson's disease

  2005cited by this paper
• Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium

  2005cited by this paper
• Clinical and neuropathological correlates of Lewy body disease

  2003cited by this paper
• Clinical and neuropathological correlates of Lewy body disease

  2003cited by this paper
• Pathoanatomy of Parkinson’s disease

  2000cited by this paper
• Advances in imaging Parkinson's disease.

  1997cited by this paper

• Myocardial sympathetic distal axon loss in subjects with Lewy pathology in three autopsy cohorts

  2025cites this paper
• Diagnostic Sensitivity and Symptomatic Relevance of Dopamine Transporter Imaging and Myocardial Sympathetic Scintigraphy in Patients with Dementia with Lewy Bodies

  2024cites this paper
• Dopaminergic neurodegeneration in Gerstmann–Sträussler–Scheinker (P102L) disease: insights from imaging and pathological examination

  2024cites this paper
• The role of 123-I-MIBG cardiac scintigraphy in the differential diagnosis between dementia with Lewy bodies and Alzheimer’s disease

  2024cites this paper
• Demenz mit Lewy-Körpern: alte und neue Erkenntnisse – Teil 1: Klinik und Diagnostik

  2023cites this paper
• The diagnostic performance of functional dopaminergic scintigraphic imaging in the diagnosis of dementia with Lewy bodies: an updated systematic review

  2023cites this paper
• Genetic Architecture and Molecular, Imaging and Prodromic Markers in Dementia with Lewy Bodies: State of the Art, Opportunities and Challenges

  2021cites this paper
• Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies.

  2020cites this paper
• Is There Any Clinical Value of Adding 123I-Metaiodobenzylguanidine Myocardial Scintigraphy to 123I-Ioflupane (DaTscan) in the Differential Diagnosis of Parkinsonism?

  2020cites this paper
• A diagnostic strategy for Lewy body disease using DAT-SPECT, MIBG and Combined index

  2020cites this paper
• The role of molecular imaging in the frame of the revised dementia with Lewy body criteria

  2019cites this paper
• Diagnostic accuracy of DAT-SPECT and MIBG scintigraphy for dementia with Lewy bodies: an updated systematic review and Bayesian latent class model meta-analysis

  2019cites this paper
• Diagnostic imaging of dementia with Lewy bodies, frontotemporal lobar degeneration, and normal pressure hydrocephalus

  2019cites this paper
• Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions

  2019cites this paper
• A comparison of visual and semiquantitative analysis methods for planar cardiac 123I-MIBG scintigraphy in dementia with Lewy bodies

  2019cites this paper
• Optimizing Parkinson’s disease diagnosis: the role of a dual nuclear imaging algorithm

  2018cites this paper
• The Utility of the Combined Use of 123I-FP-CIT and 123I-MIBG Myocardial Scintigraphy in Differentiating Parkinson's Disease from Other Parkinsonian Syndromes.

  2018cites this paper
• 123I-ioflupane SPET and 123I-MIBG in the diagnosis of Parkinson's disease and parkinsonian disorders and in the differential diagnosis between Alzheimer's and Lewy's bodies dementias.

  2018cites this paper
• Findings of 123I-MIBG Cardiac Scintigraphy: Parkinson’s Disease and Related Disorders and Others (RBD, Cardiac Diseases, DM, etc.)

  2017cites this paper
• 123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders

  2017cites this paper
• Added Value of Combined Semi-Quantitative and Visual [123I]FP-CIT SPECT Analyses for the Diagnosis of Dementia With Lewy Bodies

  2017cites this paper
• Diagnosis of dementia with Lewy bodies: can 123I-IMP and 123I-MIBG scintigraphy yield new core features?

  2017cites this paper
• Combined use of dopamine transporter imaging (DAT-SPECT) and 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy for diagnosing Parkinson's disease.

  2017cites this paper
• The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes

  2017cites this paper
• Clinical validity of presynaptic dopaminergic imaging with 123I-ioflupane and noradrenergic imaging with 123I-MIBG in the differential diagnosis between Alzheimer's disease and dementia with Lewy bodies in the context of a structured 5-phase development framework.

  2017cites this paper
• 123 I-Metaiodobenzylguanidine Myocardial Scintigraphy in Dementia with Lewy Bodies

  2017cites this paper
• Findings of MIBG Cardiac Scintigraphy: Dementia with Lewy Bodies and Related Dementia

  2017cites this paper
• Neuroimaging of Dementia with Lewy Bodies

  2017cites this paper
• Dopamine Transporter Imaging

  2017cites this paper
• 123I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography and 123I‐metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study

  2016cites this paper
• Molecular imaging of dopamine transporters.

  2016cites this paper
• (123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in α-synucleinopathies.

  2016cites this paper
• Importance of 123I-ioflupane SPECT and Myocardial MIBG Scintigraphy to Determine the Candidate of Deep Brain Stimulation for Parkinson’s Disease

  2016cites this paper
• Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer’s disease

  2015cites this paper
• Diagnostic Accuracy of 123I-Meta-Iodobenzylguanidine Myocardial Scintigraphy in Dementia with Lewy Bodies: A Multicenter Study

  2015cites this paper
• Imaging the Functional Brain-Heart Axis: Neurodegenerative Diseases

  2015cites this paper
• 123I-FP-CIT SPECT in the differential diagnosis between dementia with Lewy bodies and other dementias.

  2015cites this paper
• Biomarkers Differentiating Dementia with Lewy Bodies from Other Dementias: A Meta-Analysis

  2015cites this paper
• Skin biopsy and I‐123 MIBG scintigraphy findings in idiopathic Parkinson's disease and parkinsonism: A comparative study

  2015cites this paper
• Plasma Oligomeric Alpha‐Synuclein Is Associated With Glucocerebrosidase Activity in Gaucher Disease

  2015cites this paper
• Iodobenzylguanidine Myocardial Scintigraphy in Dementia with Lewy Bodies

  2015cites this paper
• Malattia a corpi di Lewy

  2014cites this paper
• Tesis doctoral UTILIDAD DE LA GAMMAGRAFÍA DE INERVACIÓN MIOCÁRDICA CON 123I-MIBG EN EL DIAGNÓSTICO CLÍNICO DE LA DEMENCIA DE CUERPOS DE LEWY

  2014cites this paper
• Current role and future perspectives of radioiodinated MIBG in the evaluation of dementia with Lewy bodies.

  2014cites this paper
• Maladie à corps de Lewy

  2014cites this paper
• Comparison of 123I-MIBG myocardial scintigraphy, brain perfusion SPECT, and voxel-based MRI morphometry for distinguishing between dementia with Lewy bodies and Alzheimer’s disease

  2014cites this paper
• Do CSF levels of t-Tau, p-Tau and β1-42 amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A 123I-FP-CIT study in the early stages of the disease

  2014cites this paper
• Molecular imaging biomarkers for dementia with Lewy bodies: an update

  2014cites this paper
• Myocardial scintigraphy may predict the conversion to probable dementia with Lewy bodies

  2013cites this paper
• Treatment of Dementia With Lewy Bodies

  2013cites this paper